Biotech Business Week articles from July 2003

Biotech Business Week archives from July 2003

Report says microbial genotyping is an underserved market.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- With public attention focused on outbreaks of severe acute respiratory syndrome (SARS) and monkeypox, along with fears of bioterrorism, microbiologists are increasingly finding themselves in the...

Diabetes drug reduces development of heart stent blockage.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Groundbreaking research has shown that rosiglitazone, a drug widely used by diabetes patients to lower blood sugar levels, can also prevent or dramatically reduce the development of new blockages -...

Femring launched in U.S.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Galen Holdings, PLC, (GALN) announced the availability of Femring in the United States, the only vaginally delivered estrogen therapy to provide dual symptom control, treating both the vaginal (dryness,...

Liquent launches electronic regulatory document management system.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Liquent, Inc., unveiled Liquent InSight Foundation, the company's first product in its new InSight family of solutions that integrate document, publishing, and submission management technology. ...

Phase III D9902B trial will serve as basis for Provenge approval.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Dendreon Corporation (DNDN) announced that the company has received a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA) indicating that its pivotal phase III trial,...

Lack of STD awareness challenges growth of diagnostic market.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Growth of diagnostic markets are directly dependent on an increasing awareness of the symptoms of sexually transmitted diseases (STDs), which in turn spur the demand for routine screening facilities....

Diversa receives DoD Chemical and Biological Defense Initiatives Fund award.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Diversa Corporation (DVSA) announced that one of its biodefense proposals has been selected to receive a $1.38 million award from the U.S. Department of Defense's Chemical and Biological Defense (CBD)...

Cooling heart attack patients studied.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- According to results of an initial safety and feasibility study, conducted at the Montreal Heart Institute (MHI) in Montreal, Quebec, Canada, mild hypothermia - cooling a patient's body temperature by a...

Enterprise agreement signed with Japanese firm.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Datatrak International, Inc., announced the signing of an Enterprise Agreement with Otsuka Maryland Research Institute (OMRI). Following an extensive internal evaluation of multiple EDC vendors,...

GeneEd releases new regulatory and compliance library.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- GeneEd, Inc., a provider of advanced e-learning solutions for the life science industry, announced it has created new e-learning content focused on regulatory and compliance practices and procedures....

Physicians identify that ruboxistaurin improves symptoms.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Eli Lilly and Company (LLY) announced that patients with diabetic peripheral neuropathy treated with ruboxistaurin mesylate showed improvement in Clinical Global Impression (CGI) - a globally accepted...

ICSU releases report on GM foods.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- The International Council for Science (ICSU) announced the release of a new report entitled "New Genetics, Food and Agriculture: Genetic Discoveries - Societal Dilemmas." A synthesis of more than...

A technology cure may be around the corner.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- The healthcare vertical market for networking equipment and connectivity solutions is in a period of significant evolution, according to In-Stat/MDR. The high-tech market research firm reports that...

Canadian pharmacy information management firm to use HealthWeaver.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- DataLoom Solutions has announced that the company has signed a multiyear agreement to provide its HealthWeaver technology to RxCanada, Inc. RxCanada is owned by a consortium of major Canadian pharmacy...

Clinical trial IT company announces two new clients.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Document Solutions Group, Inc., (DSG), a provider of clinical trial data collection software and services, announced two new clients, a multinational pharmaceutical company and a medical device company,...

New biomedical knowledge exchange solution introduced.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Constella Biomedical Informatics, a regulatory informatics business, introduced Constella Orion, a biomedical informatics knowledge exchange solution designed to support the research and development of...

Home Diagnostics launches SmartMarketing.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Home Diagnostics, Inc., (HDI) a manufacturer and marketer of diabetes management products, introduced SmartMarketing, a blood glucose monitoring category management program. Throughout the...

Hispanics more likely to suffer from numerous health conditions.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- New research from ACNielsen U.S. shows that, while Los Angeles-area Hispanics are more likely than non-Hispanics to suffer from a host of health-related conditions, they are less likely to purchase...

Fitzgerald named chairman of the board at orthopedics implants company.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Orthovita, Inc., (VITA) reported that it has appointed David Fitzgerald as chairman of its board of directors. Fitzgerald spent 25 years in management positions at Pfizer, Inc., serving as...

Novitron International names senior managers.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Novitron International, Inc., (NOVI) announced the appointment of Audrey Ho as senior vice president and chief operating officer, Mark Shooman as senior vice president and CFO, Vincent J. Maietta as...

Tactics work to increase awareness of disease, treatment options.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies that face limited resources and wide geographical dispersion of field-based medical programs are now creating a strong infrastructure to effectively reach and educate...

Rights to Quadramet pain therapy to be reacquired by oncology firm.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO) and Berlex Laboratories, a U.S. affiliate of Schering AG, Germany (SHR) announced an agreement whereby marketing rights held by Berlex to market Quadramet, a skeletal...

Studies suggest that delayed clinical trials common.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Upwards of 80% of clinical trials are delayed, according to separate studies conducted by CenterWatch, the McKinsey Quarterly, IBM Global Industries, and Convergence CT. The reason? Problems...

Anti-inflammatory compound enters Phase I clinical trial.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc. (CTI), a private biopharmaceutical company developing novel therapeutic products for critical care medicine, announced the initiation of a dose-escalating Phase I clinical...

Manufacturing process for lentiviral vector-based treatment described.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Oxford BioMedica presented the details of its novel manufacturing process for ProSavin for the treatment of Parkinson's disease at the BIO 2003 Annual Convention held in Washington, DC, in late June....

First biotech product for allergy-related asthma approved.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved the first biotechnology product to treat patients with a type of asthma that is related to allergies. The product, omalizumab, is a...

Cardiology device maker reports 20th consecutive quarter of revenue growth.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- CardioDynamics (CDIC) reported its 20th consecutive quarter of year-over-year revenue growth and a 30% increase in second quarter 2003 sales over the same period in the prior year. Net sales for...

FDA clearance granted for heparin coating.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) announced that its wholly-owned subsidiary, Gish Biomedical, Inc., gained U.S. Food and Drug Administration (FDA) clearance for its unique heparin coating to be...

Nestle, Colgate announce portable oral care agreement.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Nestle, S.A., and Colgate-Palmolive Co. (CL) announced an agreement to pursue on a worldwide basis the development, marketing, distribution, and sale of a portfolio of portable oral care products. ...

Research leads to findings on a curable form of hypertension.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- New research being presented at ENDO 2003, the 85th Annual Meeting of The Endocrine Society, may lead to novel treatments for atherosclerosis, improved detection of a curable form of hypertension, and...

Strattera most promoted prescription drug to managed care pharmacy executives.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Eli Lilly & Co.'s new attention deficient hyperactivity disorder medication was the prescription drug most heavily promoted to managed care pharmacy directors during the first quarter, according to...

Genentech and Biogen announce autoimmune collaboration.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) and Biogen, Inc., (BGEN) announced a collaboration for the research and development of a BR3 (BAFF-R) protein therapeutic currently in Biogen's pipeline. Financial terms...

Clinical trials IT company changes name.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Advanced Systems Development, Inc., (ASD), a provider of information technology services to the clinical trials industry, announced at the 39th Annual DIA Conference that it has changed its name and...

Genedata and Novartis expand collaboration in anti-infectives research.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Genedata, AG, a specialist for scientifically validated software systems and solutions for the life-science industry, announced a significant extension of its collaboration with Novartis. Under...

Generex announces third quarter financial results, positive results on Oralin.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced financial results for its third fiscal quarter ended April 30, 2003. The company reported a net loss for the quarter ended April 30, 2003, of $2.6...

Medical staffing company refinancing with note holders.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- ATC Healthcare, Inc., (AHN) announced that it has renegotiated its debt with the four note holders from the purchase of its largest franchise completed in January 2002 and the subordination agreement...

Private offering of convertible senior subordinated notes amounts to $125M.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Advanced Medical Optics, Inc., (AVO, AMO) announced that it has priced a private offering of $125 million of its 3.5% convertible senior subordinated notes due 2023, plus up to an additional $15...

Collaboration extended for Cetrotide.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- AEterna Laboratories, Inc., (AELA) announced the extension of the existing license agreement between its subsidiary Zentaris and Serono (SEO, SRA) for worldwide marketing rights, except in Japan, for...

New guidelines adopted to help doctors ensure safe, secure Internet prescribing.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- The American Medical Association (AMA) House of Delegates adopted guidelines to help physicians safely and securely prescribe medications to patients via the Internet. The new guidelines state...

Court upholds decision on paclitaxel-coated stents.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that the U.S. Court of Appeals for the Seventh Circuit has substantially affirmed a U.S. District Court decision in favor of Boston Scientific in its...

Enzon accesses phase III clinical candidate, ATG-Fresenius S.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Enzon Pharmaceuticals, Inc., (ENZN) announced that the company and Fresenius Biotechnology, a division of Fresenius, have signed an agreement in which Fresenius will license to Enzon exclusive North...

Monash University takes equity in Norwood Immunology.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Norwood Abbey, Ltd., (NAL), the Melbourne-based medical technologies commercialization company, announced that its subsidiary, Norwood Immunology, has entered into a full licensing agreement with...

Microbial genetic diversity-focused company plans to liquidate its assets.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- InterLink Biotechnologies (ILB) has decided to liquidate the assets of the company due to difficulties encountered in securing a suitable merger partner to allow the company to continue to expand its...

87% of pharmaceutical firms begin thought leader programs by phase II.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies should begin screening key opinion leader candidates as early as between phase I and phase II, according to new research from pharmaceutical intelligence firm Cutting Edge...

In-line pharmaceutical market research budgets under $1 million per drug.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- In-line pharmaceutical products, those products already sold on the market, receive an average $710,000 to support market research activities, according to a new study by pharmaceutical intelligence...

Media Cybernetics upgrades Gel-Pro Analyzer.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Media Cybernetics, Inc., an analytical imaging software provider, announced the upgrade release of Gel-Pro Analyzer. Gel-Pro Analyzer is designed for molecular biologists that acquire images from...

HemoSense names Ad de Waard as director, international business development.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- HemoSense, Inc., manufacturer of the portable INRatio Prothrombin Time (PT) Monitoring System, has appointed Ad de Waard to the position of director, international business development. de Waard...

New Cath-Lab survey shows significant penetration of drug eluting stents.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Millennium Research Group, a provider of global medical market intelligence, announced the findings of its new Cath-Lab Marketrack survey for May 2003. Cath-Lab Marketrack monitors monthly usage of...

Agreement established to develop and market Lucentis.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) and Novartis Ophthalmics, the eye health unit of Novartis, AG, (NVS) have entered into an agreement under which Novartis Ophthalmics will receive an exclusive license to develop...

MSA developer announces commercialization and funding objectives.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Genesis Bioventures, Inc., (GBI) announced the near-term objectives for the company in its drive to commercialize the Mammastatin Serum Assay (MSA) risk assessment tool for breast cancer. GBI...

Venture capital firm releases findings from "The Nanotech Report 2003".
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Lux Capital, a venture capital firm focused on nanotechnology, announced the release of key findings from "The Nanotech Report 2003," a more-than 500-page research report. Among the findings: ...

Phase I CAB-175 trial commences in U.S. following IND filing.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) has commenced a multidose phase I trial in the U.S. for its investigational antibiotic CAB-175 following the filing of an Investigational New Drug (IND) application...

CE Mark granted for European commercialization of DuraSeal.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Confluent Surgical, Inc., announced that it has been awarded a CE Mark (product certification) allowing the commercial distribution of its DuraSeal Dural Sealant System within the European Community....

BNP test agreement signed immunoassay agreement.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Biosite Incorporated (BSTE) and Beckman Coulter, Inc., (BEC) have signed an agreement for Beckman Coulter to manufacture and Biosite to commercialize a b-type natriuretic peptide (BNP) test for use on...

Research deal signed with Centocor on multiple proteins.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Biolex, Inc., announced the signing of a research collaboration with Centocor, Inc., a wholly owned subsidiary of Johnson & Johnson, to examine the feasibility of producing three proteins using Biolex'...

Biopharmaceutical company reports cancer therapy progress.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced that four presentations made at an annual meeting of nuclear medicine physicians and scientists indicated progress in the development and use of antibody-based...

Key milestone reached with Blue Cross/Blue Shield coverage of the Essure.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Conceptus, Inc., (CPTS) announced its Essure procedure has received positive decisions with Blue Cross/Blue Shield plans that account for nearly 43 million covered lives, or more than one-half of all...

$65M for genomics, proteomics research aimed at human health.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Allan Rock, Canadian Industry minister announced up to $65 million will be made available for a special competition on Applied Genomics and Proteomics Research in Human Health. The minister made...

Debt tender offers extended by drug delivery company.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Alaris Medical, Inc., (AMI) and its wholly-owned subsidiary, Alaris Medical Systems, Inc., announced that the companies have extended the expiration date of their cash tender offers for Alaris Medical...

Diagnostics company raises additional capital.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced that as of June 18, 2003, it has raised approximately $887,000, net of...

Disease management company added to S&P SmallCap 600 Index.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- American Healthways (AMHC) announced that it was added to Standard & Poor's "S&P SmallCap 600 Index" after the close of trading Thursday, June 26. The disease management company will be included...

Medsurge conditionally approved for TSX Venture listing.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Medsurge Medical Products Corp. (MSR) reported that its initial public offering of 3.0 million shares at $0.30 cents per share has been fully subscribed, with Calgary-based Leede Financial Markets,...

Neurovascular company completes $8.2 million preferred stock financing.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Micrus Corp. announced that the company completed the placement of $8.2 million of convertible preferred stock with an investor group led by HBM Bioventures, AG, of Switzerland. Additional...

Option exercised for additional $15M by immunotherapeutics firm.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Corixa Corporation (CRXA) announced that the initial purchaser for its recent offering of 4.25% convertible subordinated notes due 2008 has exercised its option to purchase an additional $15 million in...

Private placement investment of $3M in convertible notes.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Adherex Technologies, Inc., (AHX) announced that it has closed a private placement of convertible notes totaling approximately CDN$3.0 million. More than 70% of the subscriptions came from...

Revised second quarter earnings outlook, merger announced by biotech firm.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) reconfirmed operating earnings per share guidance for full year 2003 of $1.72 to $1.85 and announced that the company will merge with IDEC Pharmaceuticals, Inc. Biogen...

Company launches new Celsius line of equipment and disposables.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Integrated Biosystems, Inc., (IBI), a supplier of controlled freeze-thaw technology to the biopharmaceutical industry, is launching a new Celsius line of equipment and disposables. IBI has...

Proteome annotation resource, Biopendium Online, launched.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Inpharmatica, Ltd., an informatics-driven drug discovery company, announced that Biopendium Online, a new version of its premier Biopendium annotation resource, has been launched. Biopendium...

Consumers see great promise in biotechnology.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Although nearly 80% of consumers can't name a biotechnology company or product, the same number believe biotechnology will treat cancer, replace or repair damaged tissue, and be the primary source of...

Creative strategies can sustain growth in blood pressure monitors market.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- The increasing incidence of high blood pressure among the American population and the fact that blood pressure measurement is a vital statistic in determining overall health, are driving interest in...

Research process offers platforms for future product introductions.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Ziment has launched Messagez, the latest addition to its suite of market research approaches for product and business development managers launching and repositioning products in the pharmaceutical,...

GE Medical Systems to acquire Triple G Systems.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- GE Medical Systems Information Technologies, the healthcare IT business of General Electric Co. (GE), and Triple G Systems Group, Inc., (TGG) have signed a definitive transaction agreement. Under...

Point Technologies enters license agreement.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Point Technologies, Inc., and Incyte Corp. announced an agreement under which Point Tech has sublicensed U.S. patent no. 5,807,522, "Methods for Fabricating Microarrays of Biological Samples," issued...

Application filed for generic Premarin.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that it has filed an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) for an "AB" rated conjugated estrogens product....

Omega-3 fatty acids formulated as stable, dry powder.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International, Inc., (BDSI; BDSIW) announced that its subsidiary, Bioral Nutrient Delivery, LLC, has utilized its licensed and patented technology, Bioral Delivery, to formulate an...

Enrollment begins for phase I trial of SAHA.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Aton Pharma, Inc., announced that enrollment has begun in a phase I clinical trial of SAHA in patients with advanced leukemias, including acute myeloid leukemia (AML), chronic myeloid leukemia (CML),...

Company announces Proxis trial, distribution agreement, and financing.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Velocimed, Inc., a developer and manufacturer of medical devices used in the treatment of cardiological and neurological diseases, announced that it has received U.S. Food and Drug Administration (FDA)...

Generic biopharmaceuticals to hit market over next several years.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Over the next few years, a number of first-generation biopharmaceuticals will come off patent and lose marketing exclusivity, according to the Strategic Research Institute. These include several...

Early intervention with Atacand improves outcome.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- In the ACCESS trial Atacand (candesartan cilexetil) reduced the number of vascular events by 45% during 12 months following acute stroke in patients with elevated blood pressure. These data...

Enrollment commences in pivotal ARISE phase III trial of AGI-1067.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) has begun enrollment of patients in its pivotal ARISE phase III clinical trial of AGI-1067, a novel oral anti-inflammatory agent targeting atherosclerosis, the disease that...

Seven orders received for bioarchive systems in fourth quarter.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- ThermoGenesis Corp. (KOOL) announced that the company received orders for five BioArchive Systems in June bringing to seven the total number of orders received in the fourth quarter. The seven...

VaxGen to complete phase III trial in Thailand.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) has issued a response to several newspaper articles that inaccurately stated that the company was planning to withdraw from its phase III trial in Thailand. According to the...

Pharmaceutical firm initiates actions to improve profitability.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Baxter International, Inc., (BAX) announced several measures to position the company more competitively and to enhance its long-term profitability. The company plans to close 26 plasma collection...

DNASIS MAX 2.0 sequencing software new customizable workflow released.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- MiraiBio, Inc., a provider of tools for the life-science laboratory, announced the release of their next generation gene sequence analysis package, DNASIS MAX Version 2.0. Based on the company's...